Novel Tandem Desulfurization and Hydroxylation in Aqueous Media (Towards the Asymmetric Synthesis of New and Effective Anti-cancer Agents)

水介质中的新型串联脱硫和羟基化(致力于新型有效抗癌剂的不对称合成)

基本信息

  • 批准号:
    15550031
  • 负责人:
  • 金额:
    $ 2.43万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

Recent disclosures from this laboratory have demonstrated SmI_2-promoted tandem desulfurization and high erythro-selective coupling reactions of aromatic lactams with carbonyl compounds. Although significant progress, thus, has been made in advancing the versatility of sulfur-substituted lactams, the lack of studies concerning the reactivity toward simple Lewis acids is surprising except the lactol type of compounds. Herein we wish to report our successful efforts for the development of novel Lewis acid-mediated tandem reaction of phenylthio-substituted alicyclic and aromatic lactams in aqueous media, leading to the γ-hydroxylated products, whose process was further applied to the convenient total synthesis of isoindolobenzazepine natural product, chilenine.Whereas the reactions with FeCl_3 and CuI gave the desired γ-hydroxylated product, but in low yield, respectively, use of CuCl or CuBr had a dramatic effect on the rate and smoothly brought about the taget compound in almost quantitative yields under these mild and readily available conditions. We were delighted to find that the same beneficial results were again obtained in reaction employing quaternary substituted phenylthiolactams containing aliphatic and aromatic alkyl side chains by replacement of the solvent system. We further found that the use of β-substituted and α,β-disubstituted γ-phenylthiolactams as well as the aromatic one underwent convenient reactions to afford the corresponding desulfurized hydroxylactams in quite high yields. In light of the above outcome, we turned our attention to the development of novel and convenient synthetic method of isoindolobenzazepine alkaloid, chilenine and accomplished the total synthesis of natural chilenine. This process will be widely applicable to the synthesis of other fused alkaloidal natural products such as new antitumor antibiotics, UCS 1025 series containing a quaternary hydroxyl group α to the nitrogen.
该实验室的最新披露表明,芳香族乳糖与羰基化合物的SMI_2促进串联脱硫化和高红细胞选择性偶联反应。尽管在推进硫取代的乳糖的多功能性方面取得了重大进展,但缺乏关于对简单刘易斯酸的反应性的研究令人惊讶,除了乳糖型的化合物类型。 Herein we wish to report our successful efforts for the Development of novel Lewis acid-mediated tandem reaction of phenylthio-substituted alicyclic and aromatic lactams in aqueous media, leading to the γ-hydroxylated products, whose process was further applied to the convenient total synthesis of isoindolobenzazepine natural product, chilenine.Whereas the reactions with FeCl_3 and CuI gave the所需的γ-羟基化产物,但分别以低产量的使用,使用CUCL或CUBR对速率产生了巨大的影响,在这些温和且易于使用的条件下,几乎定量的产率以几乎定量的产量使Tagget化合物顺利带来。我们很高兴发现,通过替换溶液系统,采用了含有脂肪族和芳香族烷基侧链的第四纪取代苯噻吩家苯乙烷的反应,再次获得了相同的有益结果。我们进一步发现,使用β-取代和α,α,β-取代的γ-苯基硫醇酰胺以及芳族人进行了方便的反应,以提供相应的脱硫化羟基酰胺,产量很高。鉴于上述结果,我们将注意力转向了新型和方便的综合方法的异丁替苯甲酰氮生物碱,甲状腺素,并实现了天然辣椒氨酸的总合成。该过程将广泛适用于其他融合的生物碱天然产物(例如新抗肿瘤抗生素)的合成,UCS 1025系列,其中包含二羟基α与氮的二级抗生素。

项目成果

期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hidemi Yoda: "First Total Synthesis of a New Sesquiterpenoid Natural Product, (±)-3-(2,4-dihydroxybenzoyl)-4,5-dimethyl-5-(4,8-dimethyl-3(E),7(E)-nonadien-1-yl)tetrahydro-2-furanone"Tetrahedron Letters. 44. 1775-1777 (2003)
Hidemi Yoda:“首次全合成一种新的倍半萜类天然产物,(±)-3-(2,4-二羟基苯甲酰基)-4,5-二甲基-5-(4,8-二甲基-3(E),7( E)-壬二烯-1-基)四氢-2-呋喃酮”四面体快报。44. 1775-1777 (2003)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hidemi Yoda: "Novel and Stereoselective Asymmetric Synthesis of an Amino Sugar Analogue, Furanodictine A"Tetrahedron Letters. 45. 1599-1601 (2004)
Hidemi Yoda:“氨基糖类似物 Furanodictine A 的新颖和立体选择性不对称合成”四面体字母。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hidemi Yoda: "Lewis Acid-promoted Tandem Desulfurization and Hydroxylation of γ-Phenylthio-substituted lactams : Novel Synthetic Strategy of Isoindolobenzazepine Alkaloid, Chilenine"Tetrahedron Letters. 44. 9057-9060 (2003)
Hidemi Yoda:“路易斯酸促进的γ-苯硫基取代内酰胺的串联脱硫和羟基化:异吲哚苯并氮杂生物碱Chilenine的新合成策略”Tetrahedron Letters 44. 9057-9060 (2003)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hidemi Yoda: "First Total Synthesis of a New Pyrrolizidine Alkaloid, Amphorogynine A"Tetrahedron Letters. 44. 1643-1646 (2003)
尤达秀美:“首次全合成新吡咯里西啶生物碱,双性木碱 A”四面体字母。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Novel and Stereoselective Asymmetric Synthesis of an Amino Sugar Analogue, Furanodictine A
氨基糖类似物呋喃诺汀 A 的新颖立体选择性不对称合成
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hidemi Yoda;Hidemi Yoda
  • 通讯作者:
    Hidemi Yoda
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YODA Hidemi其他文献

YODA Hidemi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YODA Hidemi', 18)}}的其他基金

Development of novel bioactive organo-medicinal compounds against metabolic syndrome
开发抗代谢综合征的新型生物活性有机药物化合物
  • 批准号:
    22550032
  • 财政年份:
    2010
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Asymmetric hydroxylation based on the Lewis acid-induced weak interaction and its application to the synthesis of natural products
基于路易斯酸弱相互作用的不对称羟基化及其在天然产物合成中的应用
  • 批准号:
    18550031
  • 财政年份:
    2006
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New Development of One-electron Transfer Reaction - Application to the Total Synthesis of Biologically Active Natural Products -
一电子转移反应新进展-在生物活性天然产物全合成中的应用-
  • 批准号:
    13640530
  • 财政年份:
    2001
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel Methods for the construction of Biologically Active Natural Products based on a chiron-synthetic strategy
基于凯龙合成策略构建生物活性天然产物的新方法
  • 批准号:
    10640516
  • 财政年份:
    1998
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Construction of Asymmetric Space and Catalytic Stereoselection with C_2-Symmetrical Molecules
C_2对称分子的不对称空间构建与催化立体选择
  • 批准号:
    06640765
  • 财政年份:
    1994
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

红土镍钴矿基储能材料制备过程多相反应耦合及分离强化机制研究
  • 批准号:
    22378244
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
新型变径流化床油转化催化反应过程多尺度耦合建模与多模态鲁棒优化
  • 批准号:
    62373155
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
分子光开关相变材料光化学反应与传热耦合机理研究
  • 批准号:
    52376050
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
高盐环境下厌氧反应器耦合CNT强化偶氮染料生物降解机制
  • 批准号:
    52370067
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
高温熔炼过程中电-热-反应耦合机理及多工况协同控温增效方法
  • 批准号:
    52306097
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

MIRA: C(sp3)-H Heteroatom Incorporation Using Photoexcited Nitroarenes
MIRA:使用光激发硝基芳烃引入 C(sp3)-H 杂原子
  • 批准号:
    10714687
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
The role of geometric structure in avoidance of oxygen rebound to enable aliphatic halogenation and oxacyclization by non-heme Fe(IV)-oxo (ferryl) complexes
几何结构在避免氧反弹以实现非血红素 Fe(IV)-氧代(铁基)络合物的脂肪族卤化和氧环化中的作用
  • 批准号:
    10445980
  • 财政年份:
    2022
  • 资助金额:
    $ 2.43万
  • 项目类别:
The role of geometric structure in avoidance of oxygen rebound to enable aliphatic halogenation and oxacyclization by non-heme Fe(IV)-oxo (ferryl) complexes
几何结构在避免氧反弹以实现非血红素 Fe(IV)-氧代(铁基)络合物的脂肪族卤化和氧环化中的作用
  • 批准号:
    10701682
  • 财政年份:
    2022
  • 资助金额:
    $ 2.43万
  • 项目类别:
Deconstructive Molecular Editing Technology Involving C-C Bond Scission
涉及 C-C 键断裂的解构性分子编辑技术
  • 批准号:
    10186271
  • 财政年份:
    2021
  • 资助金额:
    $ 2.43万
  • 项目类别:
Deconstructive Molecular Editing Technology Involving C-C Bond Scission
涉及 C-C 键断裂的解构性分子编辑技术
  • 批准号:
    10553719
  • 财政年份:
    2021
  • 资助金额:
    $ 2.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了